About N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide
N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide (PubChem CID 2000757) has the molecular formula C21H21BrN4O2
and a molecular weight of 441.33 g/mol. Its IUPAC name is N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide.
Molecular Properties
| Compound Name | N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide |
| PubChem CID | 2000757 |
| Molecular Formula | C21H21BrN4O2 |
| Molecular Weight | 441.33 g/mol |
| Exact Mass | 440.08 |
| IUPAC Name | N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide |
| SMILES | CC(C)=C(NC(=O)c1ccccc1Br)C(=O)NCCc1nc2ccccc2[nH]1 |
| InChI | InChI=1S/C21H21BrN4O2/c1-13(2)19(26-20(27)14-7-3-4-8-15(14)22)21(28)23-12-11-18-24-16-9-5-6-10-17(16)25-18/h3-10H,11-12H2,1-2H3,(H,23,28)(H,24,25)(H,26,27) |
| InChIKey | SWPVRBRZVOJDEO-UHFFFAOYSA-N |
| XLogP | 3.71 |
| TPSA | 86.88 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 441.33 |
| LogP ≤ 5 | 3.71 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Analyze N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide?
The IUPAC name of N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide (CID 2000757) is N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide.
What is the SMILES notation for N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide?
The canonical SMILES for N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide is CC(C)=C(NC(=O)c1ccccc1Br)C(=O)NCCc1nc2ccccc2[nH]1.
What is the InChIKey of N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide?
The InChIKey is SWPVRBRZVOJDEO-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H21BrN4O2/c1-13(2)19(26-20(27)14-7-3-4-8-15(14)22)21(28)23-12-11-18-24-16-9-5-6-10-17(16)25-18/h3-10H,11-12H2,1-2H3,(H,23,28)(H,24,25)(H,26,27).
What are the key properties of N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide?
N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide has a molecular weight of 441.33 g/mol, XLogP of 3.71, 6 rotatable bonds, 3 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-bromobenzamide is sourced from PubChem (CID 2000757), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).